Affiliation:
1. Department of Molecular Biology and Microbial Food Safety, Swammerdam Institute for Life Sciences, University of Amsterdam, Amsterdam, The Netherlands
Abstract
ABSTRACT
The wall proteome and the secretome of the fungal pathogen
Candida albicans
help it to thrive in multiple niches of the human body. Mass spectrometry has allowed researchers to study the dynamics of both subproteomes. Here, we discuss some major responses of the secretome to host-related environmental conditions. Three β-1,3-glucan-modifying enzymes, Mp65, Sun41, and Tos1, are consistently found in large amounts in culture supernatants, suggesting that they are needed for construction and expansion of the cell wall β-1,3-glucan layer and thus correlate with growth and might serve as diagnostic biomarkers. The genes
ENG1
,
CHT3
, and
SCW11
, which encode an endoglucanase, the major chitinase, and a β-1,3-glucan-modifying enzyme, respectively, are periodically expressed and peak in M/G
1
. The corresponding protein abundances in the medium correlate with the degree of cell separation during single-yeast-cell, pseudohyphal, and hyphal growth. We also discuss the observation that cells treated with fluconazole, or other agents causing cell surface stress, form pseudohyphal aggregates. Fluconazole-treated cells secrete abundant amounts of the transglucosylase Phr1, which is involved in the accumulation of β-1,3-glucan in biofilms, raising the question whether this is a general response to cell surface stress. Other abundant secretome proteins also contribute to biofilm formation, emphasizing the important role of secretome proteins in this mode of growth. Finally, we discuss the relevance of these observations to therapeutic intervention. Together, these data illustrate that
C. albicans
actively adapts its secretome to environmental conditions, thus promoting its survival in widely divergent niches of the human body.
Publisher
American Society for Microbiology
Subject
Molecular Biology,General Medicine,Microbiology
Reference92 articles.
1. Moran G, Coleman D, Sullivan D. 2012. An introduction to the medically important Candida species, p 11–25. In Calderone RA, Clancy CJ (ed), Candida and candidiasis, 2nd ed. ASM Press, Washington, DC.
2. Candida albicans biofilms: building a heterogeneous, drug-tolerant environment
3. Finkel JS, Mitchell AP. 2012. Biofilm formation in Candida albicans, p 299–315. In Calderone RA, Clancy CJ (ed), Candida and candidiasis, 2nd ed. ASM Press, Washington, DC.
4. Candida albicans
Cell Wall Proteins
5. Covalently linked cell wall proteins ofCandida albicans and their role in fitness and virulence